Strong sterling key risk to pharma sector

When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.

For many years, it has been one of the classic growth areas of the market, driven by an ageing population with significant unmet medical needs and better access to healthcare. The global pharmaceuticals industry today generates more than $1trn in revenues each year. However, over the past decade, expectations for future growth have reduced significantly. A number of the blockbuster drugs discovered in the early 1990s have lost their patent protection, allowing generic alternatives to enter the market at a steep discount.  Brexit Blog: Fitch may cut UK's AA rating on no-deal unce...